Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.24%
|
-
|
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.27%
|
-
|
|
May 31
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$329,000
$47.08 P/Share
|
|
May 25
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
7,116
-50.41%
|
$313,104
$44.61 P/Share
|
|
Apr 28
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
4,799
-3.26%
|
$211,156
$44.88 P/Share
|
|
Apr 28
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
10,460
+6.64%
|
-
|
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
6
+1.24%
|
-
|
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.22%
|
-
|
|
Mar 28
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|
|
Mar 28
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.22%
|
-
|
|
Mar 28
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1
+1.04%
|
-
|
|
Mar 28
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|
|
Mar 28
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.22%
|
-
|
|
Feb 25
2022
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
7,483
-98.28%
|
$359,184
$48.63 P/Share
|
|
Feb 23
2022
|
Christopher Callesano Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-51.08%
|
$56,682
$47.12 P/Share
|
|
Feb 23
2022
|
Christopher Callesano Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,361
+50.0%
|
-
|
|
Feb 23
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
15,872
-10.4%
|
$745,984
$47.12 P/Share
|
|
Feb 23
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
35,863
+19.03%
|
-
|
|
Feb 23
2022
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,749
-48.71%
|
$552,203
$47.12 P/Share
|
|
Feb 23
2022
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,119
+50.0%
|
-
|
|
Feb 22
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
11,757
-45.44%
|
$552,579
$47.12 P/Share
|
|
Feb 22
2022
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
3,530
-12.01%
|
$165,910
$47.12 P/Share
|
|
Feb 22
2022
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
29,403
+50.0%
|
-
|
|
Feb 22
2022
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
53,518
-26.85%
|
$2,515,346
$47.12 P/Share
|
|
Feb 22
2022
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
10,840
-5.16%
|
$509,480
$47.12 P/Share
|
|
Feb 22
2022
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
133,798
+38.9%
|
-
|
|
Feb 22
2022
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
34,370
-20.57%
|
$1,615,390
$47.12 P/Share
|
|
Feb 22
2022
|
Kenneth Moelis Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,962
-4.0%
|
$327,214
$47.12 P/Share
|
|
Feb 22
2022
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
85,931
+33.05%
|
-
|
|
Feb 22
2022
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
33,762
-25.64%
|
$1,586,814
$47.12 P/Share
|
|
Feb 22
2022
|
Jeffrey Raich Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
6,839
-4.94%
|
$321,433
$47.12 P/Share
|
|
Feb 22
2022
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
84,411
+37.87%
|
-
|
|
Feb 22
2022
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
6,232
-45.01%
|
$292,904
$47.12 P/Share
|
|
Feb 22
2022
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,871
-11.9%
|
$87,937
$47.12 P/Share
|
|
Feb 22
2022
|
Osamu R. Watanabe General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
15,586
+49.79%
|
-
|
|
Feb 10
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,238
-1.05%
|
$71,804
$58.47 P/Share
|
|
Feb 10
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
2,815
+2.33%
|
-
|
|
Dec 02
2021
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
5,602
-4.64%
|
$341,722
$61.05 P/Share
|
|
Dec 02
2021
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
5,602
+4.43%
|
-
|
|
Dec 02
2021
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
900
-100.0%
|
$54,900
$61.05 P/Share
|
|
Dec 02
2021
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+50.0%
|
-
|
|
Dec 02
2021
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,176
-100.0%
|
$71,736
$61.05 P/Share
|
|
Dec 02
2021
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
1,176
+50.0%
|
-
|
|
Nov 26
2021
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13
+0.01%
|
-
|
|
Nov 19
2021
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
31
+3.23%
|
-
|
|
Nov 19
2021
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
57
+4.16%
|
-
|
|
Nov 19
2021
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
66
+4.16%
|
-
|
|
Nov 19
2021
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
6
+3.16%
|
-
|
|
Nov 19
2021
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
57
+4.16%
|
-
|